This study delineates a panel of transcriptionally and serologically validated biomarkers, RFC2, HSP90AB1, and YWHAZ (upregulated), and CYP2E1 and ADH4 (downregulated), that reflect core pathological processes in HCC. This evidence concerns the gene YWHAZ and hepatocellular carcinoma.